Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-11-02
1998-12-15
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 28, 549 9, 549 13, 549 72, 514431, 514445, 514446, 514448, A61K 3138, C07D33502
Patent
active
058497846
ABSTRACT:
The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
REFERENCES:
patent: 4344949 (1982-08-01), Hoefle et al.
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4703037 (1987-10-01), Huang et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4857507 (1989-08-01), Rosenberg et al.
patent: 4880938 (1989-11-01), Freidinger
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 5128346 (1992-07-01), Nadzan et al.
patent: 5256783 (1993-10-01), Gokhale et al.
Roberts et al., "Rational Design of Peptide-Based Proteinase Inhibitors", Science, 248, 358 (1900).
Erickson et al., "Design Activity and 2.8A Crystall Structure of C.sub.2 Symmetric Inhibitor Complexed to HIV-1 Protease", Science 249, 527 (1990).
Pearl et al., "Sequence specificity of Retroviral Protease"Nature, vol. 328, No. 6130, Aug. 6-12, 1987, p. 482.
Martin, Drugs of the Future, 1991 16(3), 210-212.
Meek et al., "Inhibition of HIV-1 Protease in Infected T-lymphocytes by Synthetic Peptide Analogues", Nature, 343, 90 (1990).
McQuade et al., "A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle Maturation", Science, 274, 454-456 (1990).
D.H. Rich and V.J. Hunby; Dept. Struct. Funct. Proc. Am. Peptide Inhibitors of Protease Sym. 8th ed., pp. 511-520 (1983).
Rosenberg et al., J. Med. Chem., 30, 1224-1228 (1987).
Waldholz, "merck Joins Roche . . . ", The Wall Street Journal, 17 Jul. 1995, p. B3.
Becker, International Dictionary of Medicine and Biology, p. 2316, 1986.
Ghosh, "Cyclic Sulfone-3-Carboxamides . . . ", Bioorganic & Medicinal Chemistry Letters, vol. 5, No. 1, pp. 83-88, 1995.
Ho, "Rapid Turnover of Plasma . . . ", Nature, vol. 373, pp. 123-126, Jan. 1995.
Waldholz, "Merck's Elation . . .", The Wall Street Journal, 17 Jul. 1995, p. B3.
Wel, "Viral Dynamics in Human . . . ", Nature, vol. 373, pp. 117-122, Jan. 1995.
Bertenshaw Deborah E.
Chrusciel Robert Alan
Clare Michael
Getman Daniel
Heintz Robert M.
GD Searle & Co.
Kight John
M. Mach D. Margaret
Monsanto Co.
LandOfFree
Cyclic sulfone containing retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic sulfone containing retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic sulfone containing retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1458454